Assessment of Selected Endothelial Damage Biomarkers in the Determination of Endothelial Damage in Cats With Gingivostomatitis
- PMID: 40719683
- PMCID: PMC12302593
- DOI: 10.1002/vms3.70525
Assessment of Selected Endothelial Damage Biomarkers in the Determination of Endothelial Damage in Cats With Gingivostomatitis
Abstract
Background: Feline gingivostomatitis is a chronic disease of domestic cats characterised by inflammatory lesions along the gingiva and oral cavity.
Objectives: The aim of this study was to investigate oral vascular endothelial glycocalyx damage in gingivostomatitis caused by viral infections and other causes in cats using selected biomarkers of endothelial damage.
Methods: The material of this study consisted of 55 cats with gingivostomatitis and 15 healthy cats of different age, breed and sex. A total of 34 of 55 cats with gingivostomatitis had viral infections, whereas the cause of 21 cats could not be determined. Viral diseases were diagnosed by clinical findings and rapid antigen tests. Haemogram analysis was performed from blood samples. Serum endothelin-1 (ET-1), syndecan-1 (SDC-1), myeloperoxidase-ANCA (MPO-ANCA) and interleukin-6 (IL-6) biomarker concentrations were measured using feline-specific commercial ELISA kits. Cats were treated medically for gingivostomatitis.
Results: Although 49 cats recovered with the treatment, 6 cats died. There was a significant increase in serum ET-1 and SDC-1 concentrations and no difference in serum MPO-ANCA and IL-6 concentrations in cats with gingivostomatitis. In addition, total leukocyte (WBC), granulocyte (GRA) and monocyte (MON) counts were increased in cats with gingivostomatitis.
Conclusion: Serum levels of ET-1 and SDC-1, which are biomarkers of vascular endothelial damage, were increased in cats with gingivostomatitis. It was shown that vascular endothelial damage occurs in gingivostomatitis and that the biomarkers ET-1 and SDC-1 can be used to detect this damage and have a reliable diagnostic value.
Keywords: cat; endothelial biomarker; gingivostomatitis; haematological profile.
© 2025 The Author(s). Veterinary Medicine and Science published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Evaluation of Serum Vitamin D and C Concentrations in Cats With Gingivostomatitis.Vet Med Sci. 2025 May;11(3):e70279. doi: 10.1002/vms3.70279. Vet Med Sci. 2025. PMID: 40173273 Free PMC article.
-
Blood biomarkers for the non-invasive diagnosis of endometriosis.Cochrane Database Syst Rev. 2016 May 1;2016(5):CD012179. doi: 10.1002/14651858.CD012179. Cochrane Database Syst Rev. 2016. PMID: 27132058 Free PMC article.
-
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21. Clin Orthop Relat Res. 2025. PMID: 38905450
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
References
-
- Biezus, G. , de Cristo T. G., da Silva Casa M., et al. 2023. “Progressive and Regressive Infection With Feline Leukemia Virus (FeLV) in Cats in Southern Brazil: Prevalence, Ricks Factors Associated, Clinical and Hematologic Alterations.” Preventive Veterinary Medicine 216: 105945. - PubMed
-
- Biezus, G. , Ferian P. E., Pereire I. H., et al. 2019. “Clinical and Hematological Disorders in Cats With Naturel and Progressive Infection by Feline Leukemia Virus (FeLV).” Acta Scientiae Veterinariae 47: 1629.
-
- Bouallegue, A. , Daou G., and Srivastava A. K.. 2007. “Endothelin‐1‐Induced Signaling Pathways in Vascular Smooth Muscle Cells.” Current Vascular Pharmacology 5, no. 1: 45–52. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous